当前位置: X-MOL 学术J. Lipid Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages.
Journal of Lipid Research ( IF 5.0 ) Pub Date : 2019-08-27 , DOI: 10.1194/jlr.m094235
Ian de Bus 1, 2 , Han Zuilhof 1, 3 , Renger Witkamp 2 , Michiel Balvers 2 , Bauke Albada 4
Affiliation  

Cyclooxygenase 2 (COX-2) plays a key role in the regulation of inflammation by catalyzing the oxygenation of PUFAs to prostaglandins (PGs) and hydroperoxides. Next to this, COX-2 can metabolize neutral lipids, including endocannabinoid-like esters and amides. We developed an LC-HRMS-based human recombinant (h)COX-2 screening assay to examine its ability to also convert n-3 PUFA-derived N-acylethanolamines. Our assay yields known hCOX-2-derived products from established PUFAs and anandamide. Subsequently, we proved that eicosapentaenoylethanolamide (EPEA), the N-acylethanolamine derivative of EPA, is converted into PGE3-ethanolamide (PGE3-EA), and into 11-, 14-, and 18-hydroxyeicosapentaenoyl-EA (11-, 14-, and 18-HEPE-EA, respectively). Interestingly, we demonstrated that docosahexaenoylethanolamide (DHEA) is converted by hCOX-2 into the previously unknown metabolites, 13- and 16-hydroxy-DHEA (13- and 16-HDHEA, respectively). These products were also produced by lipopolysaccharide-stimulated RAW267.4 macrophages incubated with DHEA. No oxygenated DHEA metabolites were detected when the selective COX-2 inhibitor, celecoxib, was added to the cells, further underlining the role of COX-2 in the formation of the novel hydroxylated products. This work demonstrates for the first time that DHEA and EPEA are converted by COX-2 into previously unknown hydroxylated metabolites and invites future studies toward the biological effects of these metabolites.

中文翻译:

在RAW264.7巨噬细胞中鉴定的n-3多不饱和脂肪酸-乙醇胺-共轭物的新型COX-2产物。

环氧合酶2(COX-2)通过催化PUFA氧化成前列腺素(PGs)和氢过氧化物而在炎症调节中起关键作用。紧接着,COX-2可以代谢中性脂质,包括类内源性大麻素酯和酰胺。我们开发了一种基于LC-HRMS的人类重组(h)COX-2筛选试验,以检查其还能够转化n -3 PUFA衍生的N-酰基乙醇胺的能力。我们的测定从建立的PUFA和anandamide中产生了已知的hCOX-2衍生产品。随后,我们证明了EPA的N-酰基乙醇胺衍生物二十碳五烯酰基乙醇酰胺(EPEA)被转化为PGE 3-乙醇酰胺(PGE 3-EA),并分为11-,14-和18-羟基二十二碳五烯酰基-EA(分别为11-,14-和18-HEPE-EA)。有趣的是,我们证明了二十二碳六烯基乙醇酰胺(DHEA)通过hCOX-2转化为以前未知的代谢物13-和16-羟基-DHEA(分别为13-和16-HDHEA)。这些产品也是由与DHEA孵育的脂多糖刺激的RAW267.4巨噬细胞产生的。当将选择性COX-2抑制剂塞来昔布添加到细胞中时,未检测到氧化的DHEA代谢产物,进一步突显了COX-2在新型羟基化产物形成中的作用。这项工作首次证明了DHEA和EPEA被COX-2转化为以前未知的羟基化代谢物,并鼓励对这些代谢物的生物学效应进行进一步研究。
更新日期:2020-08-21
down
wechat
bug